Advertisement

Neonatology pp 49-71 | Cite as

Congenital Malformations and Syndromes: Early Diagnosis and Prognosis in Neonatal Medicine

  • Giovanni Corsello
  • Mario Giuffrè
Reference work entry

Abstract

Congenital malformations are defects of the morphogenesis of organs or body regions identified during intrauterine development or at birth. They may be isolated and single or multiple. Their global birth prevalence is about 2–3%. Congenital defects may be caused by genetic and/or environmental factors, acting singly or in combination. A deep knowledge of the family and pregnancy histories, of the congenital anomalies and/or dysmorphic features’ classification, as well as of the most appropriate cytogenetic and/or molecular genetic tests may facilitate the neonatologist to the newborn’s correct assessment and management.

References

  1. Abu-Amero S, Monk D, Frost J et al (2008) The genetic aetiology of Silver-Russell syndrome. J Med Genet 45:193–199CrossRefGoogle Scholar
  2. Barry T (2015) Genetics counseling in the genomic era. https://www.jax.org. Accessed 6 Apr 2016
  3. Barry SC, Walsh CA, Burke AL et al (2015) Natural history of fetal trisomy 13 after prenatal diagnosis. Am J Med Genet A 167(1):147–150CrossRefGoogle Scholar
  4. Bhuiyan ZA, Klein M, Hammond P et al (2006) Genotype-phenotype correlations of 39 patients with Cornelia de Lange syndrome: the Dutch experience. J Med Genet 43:568, 43:5CrossRefGoogle Scholar
  5. Biesecker LG, Spinner NB (2013) A genomic view of mosaicism and human disease. Nat Rev Genet 14(5):307–320CrossRefGoogle Scholar
  6. Blum WF, Ross JL, Zimmermann AG et al (2013) GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab 98(8):E1383–E1392CrossRefGoogle Scholar
  7. Bodian DL, Chan T-F, Poon A et al (2009) Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Hum Mol Genet 18:463–471CrossRefGoogle Scholar
  8. Botto LD, May K, Fernhoff PM et al (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107CrossRefGoogle Scholar
  9. Dixon MJ (1996) Treacher Collins syndrome. Hum Mol Genet 1996:1391–1396CrossRefGoogle Scholar
  10. Doherty ES, Lacbawan F, Hadley DW (2007) Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet 143A:3204–3215CrossRefGoogle Scholar
  11. Donnai D, Winter RM (1995) Congenital malformation syndromes. Chapman & Hall Medical, LondonGoogle Scholar
  12. Dubourg C, David V, Gropman A et al (2011) Clinical utility gene card for: holoprosencephaly. Eur J Hum Genet 19(1):118, preceedingCrossRefGoogle Scholar
  13. Eggermann T, Buiting K, Temple IK (2011) Clinical utility gene card for: Silver-Russell syndrome. Eur J Human Genet 19(3):e1–e3Google Scholar
  14. Ferrero GB, Baldassarre G, Delmonaco AG et al (2008) Clinical and molecular characterization of 40 patients with Noonan syndrome. Eur J Med Genet 51:566–572CrossRefGoogle Scholar
  15. Fischetto R, Causio F, Corso G et al (1997) Pseudodiastrophic dysplasia type Burgio in a newborn. Am J Med Genet 71(2):222–225CrossRefGoogle Scholar
  16. Giuffrè M, Piro E, Corsello G (2012) Prematurity and twinning. J Matern-Fetal Neonatal Med 25(sup3):6–10CrossRefGoogle Scholar
  17. Gorlin RJ, Cohen MM Jr, Levin LS (1990) Syndromes of the head and neck. Oxford University Press, New YorkGoogle Scholar
  18. Gunay-Aygun M, Schwartz S, Heeger S et al (2001) The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 108, e92CrossRefGoogle Scholar
  19. Hacıhamdioğlu B, Hacıhamdioğlu D, Delil K (2015) 22q11 deletion syndrome: current perspective. Appl Clin Genet 8:123CrossRefGoogle Scholar
  20. Jones KL (1997) Smith’s recognizable patterns of human malformations. WB Saunders, PhiladelphiaGoogle Scholar
  21. Karmiloff-Smith A, Al-Janabi T, D’Souza H, et al (2016) The importance of understanding individual differences in Down syndrome. F1000Research, 5Google Scholar
  22. Lami F, Carli D, Ferrari P et al (2013) Holoprosencephaly: report of four cases and genotype–phenotype correlations. J Genet 92(1):97–101CrossRefGoogle Scholar
  23. Loeys BL, Dietz HC, Braverman AC et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476–485CrossRefGoogle Scholar
  24. Mansour S, Offiah AC, McDowall S et al (2002) The phenotype of survivors of campomelic dysplasia. J Med Genet 39:597–602CrossRefGoogle Scholar
  25. McDonald-McGinn DM, Sullivan KE (2011) Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine 90(1):1–18CrossRefGoogle Scholar
  26. Mitanchez D, Yzydorczyk C, Siddeek B et al (2015) The offspring of the diabetic mother – short- and long-term implications. Best Pract Res Clin Obstet Gynaecol 29(2):256–269CrossRefGoogle Scholar
  27. Paludetti G, Conti G, Di Nardo W et al (2012) Infant hearing loss: from diagnosis to therapy. Acta Otorhinolaryngol Ital 32:347–370PubMedPubMedCentralGoogle Scholar
  28. Petit F, Escande F, Jourdain AS et al (2014) Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause. Clin Genet 86(3):246–251CrossRefGoogle Scholar
  29. Porter FD (2008) Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 16(5):535–541CrossRefGoogle Scholar
  30. Ramos FJ, Puisac B, Baquero-Montoya C, et al (2015) Clinical utility gene card for: Cornelia de Lange syndrome. Eur J Hum Genet 23(10):e1–e4CrossRefGoogle Scholar
  31. Roberts AE, Allanson JE, Tartaglia M et al (2013) Noonan syndrome. Lancet 381(9863):333–342CrossRefGoogle Scholar
  32. Rodríguez-Caballero Á, Torres-Lagares D, Yáñez-Vico RM et al (2012) Assessment of orofacial characteristics and oral pathology associated with cri-du-chat syndrome. Oral Dis 18(2):191–197CrossRefGoogle Scholar
  33. Rubinstein-Taybi syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K (eds). University of Washington, Seattle, GeneReviews®eneReviewsRJ Seattle. 1993–2016Google Scholar
  34. Schorry EK, Keddache M, Lanphear N et al (2008) Genotype-phenotype correlations in Rubinstein-Taybi syndrome. Am J Med Genet 146A:2512–2519CrossRefGoogle Scholar
  35. Shastry SM, Kolte SS, Sanagapati PR (2012) Potter’s sequence. J Clin Neonatol 1(3):157CrossRefGoogle Scholar
  36. Shaw-Smith C (2006) Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology. J Med Genet 43(7):545–554CrossRefGoogle Scholar
  37. Smolkin T, Soudack M, Goldstein I et al (2008) Prune belly syndrome: expanding the phenotype. Clin Dysmorphol 17:133–135CrossRefGoogle Scholar
  38. Solomon BD (2011) Vacterl/Vater association. Orphanet J Rare Dis 6(56):5Google Scholar
  39. Thouvenin B, Djadi‐Prat J, Chalouhi C et al (2013) Developmental outcome in Pierre Robin sequence: a longitudinal and prospective study of a consecutive series of severe phenotypes. Am J Med Genet A 161(2):312–319CrossRefGoogle Scholar
  40. Tiecke F, Katzke S, Booms P et al (2001) Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24–40. Eur J Hum Genet 9:13, 9:1CrossRefGoogle Scholar
  41. Trainor PA, Dixon J, Dixon MJ (2009) Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet 17(3):275–283CrossRefGoogle Scholar
  42. Twining P, McHugo JM, Pilling DW (2000) Textbook of fetal abnormalities. Churchill Livingstone, LondonGoogle Scholar
  43. Wassif CA, Maslen C, Kachilele-Linjewile S (1998) Mutations in the human sterol delta-7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63:5555GeCrossRefGoogle Scholar
  44. Weksberg R, Shuman C, Beckwith JB (2010) Beckwith–Wiedemann syndrome. Eur J Hum Genet 18(1):8–14CrossRefGoogle Scholar
  45. Wiedemann HR, Kunze J, Dibbern H (1992) An atlas of clinical syndromes. A visual aid to diagnosis, 2nd edn. Wolfe Publishing, LondonGoogle Scholar
  46. Wilkie AOM, Slaney SF, Oldridge M et al (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9(165t 9):1Google Scholar
  47. Winter TC, Kennedy AM, Woodward PJ (2015) Holoprosencephaly: a survey of the entity, with embryology and fetal imaging. Radiographics 35(1):275–290CrossRefGoogle Scholar
  48. Wolfgram PM, Carrel AL, Allen DB (2013) Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr 25:509–514CrossRefGoogle Scholar
  49. Wu J, Springett A, Morris JK (2013) Survival of trisomy 18 (Edwards Syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004–2011. Am J Med Genet A 161(10):2512–2518Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Sciences for Health Promotion and Mother and Child CareUniversity of PalermoPalermoItaly

Personalised recommendations